Skip to main content
. 2013 Jun 5;7(4):397–406. doi: 10.1111/crj.12026

Figure 1.

Figure 1

Schematic illustrating study design. Note: FF/VI 100/25 μg and fluticasone furoate (FF)/vilanterol (VI) 200/25 μg are nominal doses, representing emitted doses of FF and VI via the dry powder inhaler of 92/22 μg and 184/22 μg, respectively. *All inhaled dosing once daily in the evening. All oral capsules taken in the morning on the last 7 days of study only. ‡24-h serum cortisol and urine cortisol sampling. §Pharmacokinetic sampling.